ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder.
about
The renin-angiotensin-aldosterone system in patients with depression compared to controls--a sleep endocrine studyProfiling trait anxiety: transcriptome analysis reveals cathepsin B (Ctsb) as a novel candidate gene for emotionality in miceChemotherapy-Induced Cardiotoxicity: Pathophysiology and PreventionA hypomorphic vasopressin allele prevents anxiety-related behavior.A role for glucocorticoid-signaling in depression-like behavior of gastrin-releasing peptide receptor knock-out mice.Pluronics and MDR reversal: an update.Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary.Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress.Drug transporters, the blood-testis barrier, and spermatogenesisInteractions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings.Aging and stress: past hypotheses, present approaches and perspectivesGlucocorticoid receptor function in vitro in patients with major depression.Association between ABCB1 Polymorphisms and Antidepressant Treatment Response in Taiwanese Major Depressive Patients.The androgen metabolite, 5α-androstane-3β,17β-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells.Steroid biosynthesis and renal excretion in human essential hypertension: association with blood pressure and endogenous ouabain.The glucocorticoid receptor: part of the solution or part of the problem?Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review)Drug transporters: gatekeepers controlling access of xenobiotics to the cellular interior.A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild-type and ABCB1A/B-deficient mice.Changes in the brain accumulation of glucocorticoids in abcb1a-deficient CF-1 mice.Central nervous system (CNS) delivery of glucocorticoids is fine-tuned by saturable transporters at the blood-CNS barriers and nonbarrier regions.Intrahippocampal corticosterone response in mice selectively bred for extremes in stress reactivity: a microdialysis study.Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior.Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels.Association of MDR1 C3435T polymorphism with bipolar disorder in patients treated with valproic acid.Behavioural consequences of p-glycoprotein deficiency in mice, with special focus on stress-related mechanisms.ATR-101 inhibits cholesterol efflux and cortisol secretion by ATP-binding cassette transporters, causing cytotoxic cholesterol accumulation in adrenocortical carcinoma cells.
P2860
Q24796928-9A045B2C-7381-47B1-8976-0FEA629FF272Q28740918-418364DB-5BE2-471A-B23E-FC0C32687926Q30399577-801A56DD-4888-4DD1-82FD-DD00772C33FCQ33428525-8FC0D2F2-5D8B-4394-947D-C9B67F9BCFDCQ33799696-98998E8D-65F2-42BB-A83C-DE5204D1EA50Q34005678-A9C0A47D-91AD-4012-AA36-47DF5FA38944Q35027962-904FB571-4E6F-495A-9A17-7E6676F97CF2Q35209207-28728CD0-2A06-4A37-ADC8-160B1C65565DQ35240133-E4FD5487-5D16-491C-98F5-73AFCE8BC93BQ35708089-648261FC-8BF6-483C-9A62-65B99F209B9AQ35806723-2FC16865-3A18-4B1A-B454-423027D8E3D7Q36194741-56079670-77B5-4B8B-800B-D3C53C694365Q36325439-0F6F0CFF-759F-426F-94A5-8A48D7ED6466Q36439650-342AB46A-8CB6-4C19-9FBD-45674CF5574DQ36456067-B5414F3C-0D7D-4D12-B169-A09824BEFE1DQ36511702-1528D2E4-E964-48DB-9D69-D521B52B1FC3Q36643541-E3049EAA-6B70-4D69-9FEC-C1E03533DC33Q37514340-5A2D403A-F022-43B5-9994-EFB5460BB92DQ38290046-776A61AF-360F-4768-B4FA-2B3B0791C759Q41508060-069F14A5-B6F4-418B-8F11-C859A00FC62BQ41811241-1FE26787-B87A-4F90-A456-938FEB160856Q42927357-C68D6A1F-6FCE-4A90-A342-04B2AA062AE5Q46365946-D7FC10BA-4472-4350-B3DF-AB92DDB1BD9DQ46727021-2B3A0877-8600-4FF7-971E-18483369FDE9Q46828032-165E96C0-9BCB-46E1-B580-D35CC0DFEBDFQ48008520-7BCB8BF2-7E78-4A02-B650-21091C860E67Q48121227-819F4976-30B8-435D-8171-26EE84E126F7
P2860
ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
ABCB1 (MDR1)-type P-glycoprote ...... ations for affective disorder.
@en
type
label
ABCB1 (MDR1)-type P-glycoprote ...... ations for affective disorder.
@en
prefLabel
ABCB1 (MDR1)-type P-glycoprote ...... ations for affective disorder.
@en
P2093
P2860
P356
P1476
ABCB1 (MDR1)-type P-glycoprote ...... ations for affective disorder.
@en
P2093
Adelheid E Kresse
Elisabeth B Binder
Marianne B Müller
Martin E Keck
Rainer Landgraf
Thomas P Hagemeyer
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300257
P407
P577
2003-11-01T00:00:00Z
P5875
P6179
1000489281